Search hospitals
>
Pennsylvania
>
Philadelphia
Abramson Cancer Center of the University of Pennsylvania
Claim this profile
Philadelphia, Pennsylvania 19104
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Ovarian Cancer
Conducts research for Pancreatic Cancer
947 reported clinical trials
74 medical researchers
Summary
Abramson Cancer Center of the University of Pennsylvania is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Ovarian Cancer, Pancreatic Cancer and other specialties. Abramson Cancer Center of the University of Pennsylvania is involved with conducting 947 clinical trials across 635 conditions. There are 74 research doctors associated with this hospital, such as Angela DeMichele, MD, Arati Desai, MD, Amy Clark, and Mark O'Hara, MD.
Area of expertise
Breast Cancer
Abramson Cancer Center of the University of Pennsylvania has run 120 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Abramson Cancer Center of the University of Pennsylvania has run 111 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Angela DeMichele, MD
Abramson Cancer Center of the University of Pennsylvania
8 years of reported clinical research
Arati Desai, MD
Abrams Cancer Center of the University of Pennsylvania
7 years of reported clinical research
Amy Clark
University of Pennsylvania
2 years of reported clinical research
Mark O'Hara, MD
University Of Pennsylvania
2 years of reported clinical research
Clinical Trials running at Abramson Cancer Center of the University of Pennsylvania
Breast Cancer
Lung Cancer
Ovarian Cancer
Cancer
Breast cancer
Pancreatic Cancer
Bladder Cancer
Testicular cancer
Prostate Cancer
Esophageal Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Abramson Cancer Center of the University of Pennsylvania?
Abramson Cancer Center of the University of Pennsylvania is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Ovarian Cancer, Pancreatic Cancer and other specialties. Abramson Cancer Center of the University of Pennsylvania is involved with conducting 947 clinical trials across 635 conditions. There are 74 research doctors associated with this hospital, such as Angela DeMichele, MD, Arati Desai, MD, Amy Clark, and Mark O'Hara, MD.
Where is Abramson Cancer Center of the University of Pennsylvania located?
**Directions to Abramson Cancer Center, University of Pennsylvania, Philadelphia:** - Take I-76 East to Exit 346B, University Avenue. - Turn right onto Civic Center Boulevard. - For real-time driving directions based on current traffic, consider using Waze.
Who should I call to ask about financial aid or insurance network?
**Abramson Cancer Center of the University of Pennsylvania - Financial and Insurance Assistance** - **Financial Counseling Assistance:** Contact Tonya Boyer via email at Tonya.Boyer@pennmedicine.upenn.edu or by phone at 610-738-2510. - **Insurance-Related Inquiries:** Reach out to Penn Medicine's customer service at 800-406-1177. - **General Questions about Navigating Cancer Care:** Call 800-789-7366 (PENN).
What insurance does Abramson Cancer Center of the University of Pennsylvania accept?
The Abramson Cancer Center of the University of Pennsylvania accepts most major insurance plans. Patients are advised to confirm their insurance coverage with their provider before receiving care. Penn Medicine, including the Abramson Cancer Center, offers comprehensive care under various health plans, covering cancer and heart conditions.
What awards or recognition has Abramson Cancer Center of the University of Pennsylvania received?
The Abramson Cancer Center at the University of Pennsylvania is renowned for its exceptional cancer care, earning accolades from the Commission on Cancer (CoC). In 2023, four of its researchers were distinguished with prestigious awards from the American Association for Cancer Research (AACR).
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.